Fig. 2. Activated, OX40hiGITRhi Treg are functionally suppressive and associate with nonresponse to PD-1 blockade.

(A) Functional analysis of OX40loGITRlo and OX40hiGITRhi TIL-Treg–mediated suppression of conventional CD4+T cell (Tconv) proliferation. TIL-Treg from patients MD017–0157, MD017–0092, MD017–0115, MD017–0124, and MD017–0116 were combined to ensure sufficient Treg numbers for this experiment (n = 1). (B) Volcano plot showing differential expression between the Activated (1)/OX40hiGITRhi cluster (right) versus all other Treg (left) when analyzing all tumor samples (n = 25). Each dot represents one gene. False discovery rate (FDR) < 0.05 is considered significant (blue/red dots). LAG3, TNFRSF18, and TNFRSF4 represent the top three most differentially expressed genes in the Activated (1)/OX40hiGITRhi Treg (red dots). (C) Overlay of the Activated Treg score on the TIL-Treg UMAP for each response/treatment group. Red indicates higher expression; blue indicates lower expression. (D) The frequency of Treg with a high Treg activation score is shown for tumor (left) and adjacent NL (right) from nonresponders (NR; red), responders (R; blue), and treatment-naive patients (Tx-naive; green). Comparisons were performed at the individual patient level using Wilcoxon rank test. (E) Clonotype sharing pattern across Treg subsets. The frequencies of Treg TCR clones that were detected in at least two Treg clusters were calculated and are shown on a heatmap. (F) Diffusion plot with RNA velocity for the Activated (1)/ OX40hiGITRhi and Activated (3) clusters (among which most clonotype sharing was observed). (G) Boxplots showing the relative proportion of Activated (1)/OX40hi GITRhi and Activated (3) clusters by R (blue), NR (red), and treatment-naïve status (green). (H) A violin plot shows TNFSF4 (OX40L) expression by neoantigen-specific (red) and flu-specific (blue) CD8 TILs from the same neoadjuvant-treated patients. (I) Violin plot comparing TNFSF4 (OX40L) expression by neoantigen-specific CD8+ TIL between nonresponding (red)and responding (blue) tumors. (J) Gene set enrichment analysis to evaluate differing biological functions of ex vivo OX40L, 41BBL, and GITRL agonism in sorted human TIL-Treg. TIL-Treg from patients MD043–011 and MD01–019 were combined to ensure sufficient Treg numbers for this experiment (n = 1). NF-κB, nuclear factor κB.